NPPA fixed revised retail price of 1 formulation: February 2023

Download NPPA notification No. S.O. 881(E) dt 24-02-2023

332
NPPA National Pharmaceutical Pricing Authority
Picture: Pixabay

Download NPPA notification No. S.O. 881(E) dt 24-02-2023, the link is given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 1 formulation under the Drugs (Prices Control) Order, 2013, vide S.O. 881(E) dt 24-02-2023 based on the decision of the 109th Authority meeting dated 21-02-2023.

This price fixation followed the decision of the 109th Authority meeting on February 21, 2023

The notification states as under:

In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Table

Sl. No.Name of the FormulationDosage form & StrengthUnitRetail Price (Rs.)DoP (i) Review no. & Date (ii) Letter no. and DateExisting SO number & dateManufacturer & Marketing Company respectively
(1)(2)(3)(4)(5)(6)(7)(8)
1.Methylcobalamin, Alpha Lipoic Acid, Vitamin D3, Pyridoxine Hydrochloride & Folic Acid TabletEach film coated tablet contains: Methylcobalamin IP 1500mcg, Alpha Lipoic Acid USP 100mg, Vitamin D3 IP 1000 IU, Pyridoxine Hydrochloride IP 3mg Folic Acid IP 1.5mg1 Tablet12.2331015/7/2021- Pricing dated 17.09.20213400(E) dated 19.08.2021 (at Sl. No. 10)M/s Akums Drugs & Pharmaceuticals Limited / M/s Abbott Healthcare Pvt. Ltd.

Note:
(a) The manufacturer of the above-mentioned formulations, i.e., the “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013.

The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e.. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules,
including manufacturing license permission from the competent authority, i.e., the central or state licensing authority, as may be applicable, by the concerned manufacturer/marketing company.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per the instant price notification and notes specified hereinabove, then the concerned manufacturer / marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

Latest on National Pharmaceutical Pricing Authority (NPPA)

Latest notifications – DPCO / NPPA

NPPA updated price lists: Download

Latest Notifications: EC Act (Essential Commodities Act)

FAQs – On DPCO: Drugs (Prices Control) Order, 2013

National List of Essential Medicines (NLEM)

NPPA fixed Ceiling price of 1 scheduled formulation: February 2023

NPPA revised Ceiling price of 80 scheduled formulations: February 2023

NPPA fixed retail price of 74 formulations: February 2023

NPPA fixed retail price of 18 formulations: February 2023

NPPA fixed Ceiling price of 17 scheduled formulations: January 2023

NPPA revised Ceiling price of 111 scheduled formulations: January 2023

USFDA issues Form 483 with 4 observations to Indoco Remedies, Goa

Attack on doctors: OPD services shut across the state as medicos protest

NPPA fixed Ceiling price of 1 scheduled formulation: February 2023

Private hospital fined Rs 1 lakh for littering ‘Biomedical Waste’

Spurious drugs worth Rs 2 lakh seized, distributor arrested

NPPA revised Ceiling price of 80 scheduled formulations: February 2023

India aims to be the world’s most respected drugs regulator: HM

Duties and responsibilities of QA person in Pharma Industry

NPPA fixed retail price of 74 formulations: February 2023

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news